Skip to main content
. 2010 Apr 9;22(3):201–209. doi: 10.1093/intqhc/mzq018

Table 1.

Guidelines used in identifying quality indicators

1 ACC/AHA Guideline update for the management of patients with unstable angina and non-ST-segment elevation myocardial infarction, 2002
2 ACC/AHA guidelines for the evaluation and management of chronic heart failure in the adult, 2001
3 ACC/AHA guidelines for the management of patients with acute myocardial infarction. 1999 updated version, p. 141
4 ACC/AHA/ACP-ASIM guidelines for the management of patients with chronic stable angina, 1999
5 ACC/AHA/NHLBI clinical advisory on the use and safety of statins. J Am Coll Cardiol 2002;40(3).
6 AHA scientific statement: secondary prevention of coronary heart disease in the elderly. Circulation 2002
7 AHA/ACC guidelines for preventing heart attack and death in patients with atherosclerotic cardiovascular disease: 2001 update.
8 American Diabetes Association: clinical practice recommendations. Diabetes Care 2002: S51
9 Cardiac rehabilitation. A national clinical guideline, Edinburgh, Scotland: Scottish Intercollegiate Guidelines Network (SIGN), 2002, p. 32
10 Congestive heart failure in adults. Institute for clinical systems improvement, 2002
11 Executive summary of the third report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). JAMA 2001
12 Institute of clinical systems improvement guidelines; treatment of acute myocardial infarction, 2001
13 JNC VI: risk stratification and treatment of recommendations. 1999 Clinical advisory update: treatment of hypertension and diabetes.
14 NIH/NHLBI clinical guidelines on the identification, evaluation and treatment of overweight and obesity in adults, 1998
15 Secondary prevention of coronary heart disease following myocardial infarction. SIGN publication 41, 2000
16 SIGN publication No. 55: Management of diabetes. Management of diabetic cardiovascular disease, 2001, p. 14
17 The pharmacological management of chronic heart failure. VA National Clinical Practice Guidelines Group, 2001
18 The sixth report of the JNC on prevention, detection, evaluation and treatment of high blood pressure, 1997
19 The Thrombosis Interest Group of Canada-Practice Treatment guidelines Post-MI, 2002
20 Treating tobacco use and dependence. A clinical practice guideline. U.S. Department of Health and Human Services, Public Health Service, 2000
21 University of Newcastle upon Tyne: prophylaxis for patients who have experienced a myocardial infarction: drug treatment, cardiac rehabilitation and dietary manipulation, 2001.
22 AACE/ACE position statement on the prevention, diagnosis and treatment of obesity. 1998 Revision. Endocrine Practice 1998:P297